The Core Group (CG) provides leadership and sets the strategic direction for the programs of the WGND. It facilitates and accelerates decision-making and acts as a catalyst for effective implementation of programs and initiatives developed by the membership.
The CG is composed of the WGND Co-Chairs, the Leaders of the WGND Subgroups and a WGND Community Representative. The WGND Secretariat works with the CG to implement the strategic direction and initiatives of the WGND, develop action items and manage and administer WGND programs and the membership.

Barbara Laughon, PhD
Office of the Director Division of Microbiology and Infectious Diseases
Mel Spigelman, MD
Global Alliance for TB Drug Development
Thomas Dick
Department of Microbiology
Petros C. Karakousis, M.D.
Center for TB Research, Johns Hopkins University
Barbara Laughon, PhD
Office of the Director Division of Microbiology and Infectious Diseases
Matt Price
Harvard School of Public Health
Jacques Grosset, MD
Center for TB Research
Tawanda Gumbo
UT Southwestern Medical Center
Christian Lienhardt, MD, PhD
Stop TB Partnership Secretariat
David McNeeley
Medical Service Corporation International (MSCI)
Albert Makone
Wim Vandevelde
Chair, European AIDS Treatment Group
Cherise Scott, PhD, MPH
Global Alliance for TB Drug Development